vimarsana.com

Latest Breaking News On - Michellel odonoghue - Page 1 : vimarsana.com

Sustained Reductions in Lp(a) Achieved With Novel siRNA Drug

Muvalaplin and Olpasiran Show Promise in Lowering Lp(a)

Amgen presents late-breaking Phase 2 olpasiran data at ESC 2023

Amgen today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA (siRNA) during the Late-Breaking Science Session at the European Society of Cardiology (ESC) Annual Meeting being held in Amsterdam. In the off-treatment extension period, olpasiran showed a lasting effect on Lp(a) reduction nearly a year after the last dose.

Successful early studies reported for two Lp(a)-lowering therapies

Successful early studies reported for two Lp(a)-lowering therapies
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.